A REVIEW ARTICLE ON 3D PRINTING TECHNOLOGY IN PHARMACEUTICALS
IJRTI2003018
Volume 5, Issue 3
Page 105 - 113
March 2020
205,630 Downloads
PublishedOpen AccessResearch PaperTransparent Peer ReviewedCC BY 4.0
ISSN2456-3315
Impact Factor10.57
UGC CAREApproved
Low Cost₹599 / $45
CrossRefDOI
ESTD2016
Peer ReviewTransparent
AccessOpen
Submission: Always Open
Paper Title
A REVIEW ARTICLE ON 3D PRINTING TECHNOLOGY IN PHARMACEUTICALS
Authors
DR.K.V. RATNAMALA , T.SWETHA REDDY
Keywords
3D Printing techniques, Personalized medicine, Polypill, Applications, Challenges
Abstract
The aim of this present article is to present the information regarding the 3D printing techniques suitable for pharmaceutical manufacturing and also their applications to the development of drug dosage forms, indicating the feasibility of this technology in regular commercial production. Three-dimensional printing (3DP) technology allows fabrication of 3D objects with various geometrics in a layer-by-layer process. Some advantages of 3DP methods over the conventional manufacturing processes includes customization of medicines with individually adjusted doses, the ability to fabricate the sophisticated and complex solid dosage forms, on-demand manufacturing, and cost-effectiveness. The present review focused on briefing various techniques, applications of 3D printing in pharmaceutical technology . Furthermore, recent years have seen an increasing interest in applying 3DP technology to the pharmaceutical manufacturing of the drug products and development of various drug delivery systems. However 3DP technology exhibits many potential medical and economic benefits, there are also some technical and regulatory challenges restricting the wide applications of 3DP technology to pharmaceutical products. Accordingly, the continuous innovation and refinement in 3DP methods are needed to overcome the current limitations and facilitate patient-specific health care with on-demand tailored medications in the future.
Choose the style your journal or department asks for, then copy it.
Every version below is generated from this paper's own record.
IJRTI — journal style
"A REVIEW ARTICLE ON 3D PRINTING TECHNOLOGY IN PHARMACEUTICALS", IJRTI - International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2456-3315, Vol.5, Issue 3, page no.105 - 113, March-2020, Available :https://ijrti.org/papers/IJRTI2003018.pdf
APA — 7th edition
RATNAMALA, D. K. V., & REDDY, T. S. (2020). A REVIEW ARTICLE ON 3D PRINTING TECHNOLOGY IN PHARMACEUTICALS. International Journal for Research Trends and Innovation, 5(3), 105 - 113. https://ijrti.org/viewpaperforall.php?paper=IJRTI2003018
MLA — 9th edition
RATNAMALA, DR.K.V., and T.SWETHA REDDY. "A REVIEW ARTICLE ON 3D PRINTING TECHNOLOGY IN PHARMACEUTICALS." International Journal for Research Trends and Innovation, vol. 5, no. 3, 2020, pp. 105 - 113, https://ijrti.org/viewpaperforall.php?paper=IJRTI2003018.
Chicago — 17th, bibliography
RATNAMALA, DR.K.V., and T.SWETHA REDDY. "A REVIEW ARTICLE ON 3D PRINTING TECHNOLOGY IN PHARMACEUTICALS." International Journal for Research Trends and Innovation 5, no. 3 (2020): 105 - 113. https://ijrti.org/viewpaperforall.php?paper=IJRTI2003018.
Harvard — author–date
RATNAMALA, D.K.V. and REDDY, T.S. (2020) 'A REVIEW ARTICLE ON 3D PRINTING TECHNOLOGY IN PHARMACEUTICALS', International Journal for Research Trends and Innovation, 5(3), pp. 105 - 113. Available at: https://ijrti.org/viewpaperforall.php?paper=IJRTI2003018
IEEE — numbered reference
D. K. V. RATNAMALA and T. S. REDDY, "A REVIEW ARTICLE ON 3D PRINTING TECHNOLOGY IN PHARMACEUTICALS," IJRTI, vol. 5, no. 3, pp. 105 - 113, Mar. 2020.
Vancouver — biomedical
RATNAMALA DKV, REDDY TS. A REVIEW ARTICLE ON 3D PRINTING TECHNOLOGY IN PHARMACEUTICALS. IJRTI. 2020 Mar;5(3):105 - 113.
AMA — 11th edition
RATNAMALA DKV, REDDY TS. A REVIEW ARTICLE ON 3D PRINTING TECHNOLOGY IN PHARMACEUTICALS. IJRTI. 2020;5(3):105 - 113. Accessed at https://ijrti.org/viewpaperforall.php?paper=IJRTI2003018
BibTeX — Zotero, Mendeley, LaTeX
@article{IJRTI2003018,
author = {DR.K.V. RATNAMALA and T.SWETHA REDDY},
title = {A REVIEW ARTICLE ON 3D PRINTING TECHNOLOGY IN PHARMACEUTICALS},
journal = {International Journal for Research Trends and Innovation},
volume = {5},
number = {3},
pages = {105 - 113},
year = {2020},
month = {March},
issn = {2456-3315},
url = {https://ijrti.org/viewpaperforall.php?paper=IJRTI2003018}
}
RIS — EndNote, RefWorks
TY - JOUR
AU - RATNAMALA, DR.K.V.
AU - REDDY, T.SWETHA
TI - A REVIEW ARTICLE ON 3D PRINTING TECHNOLOGY IN PHARMACEUTICALS
T2 - International Journal for Research Trends and Innovation
JA - IJRTI
VL - 5
IS - 3
PY - 2020
SN - 2456-3315
UR - https://ijrti.org/viewpaperforall.php?paper=IJRTI2003018
SP - 105
EP - 113
ER -
International Journal for Research Trends and InnovationPublished by IJRTI (JW Publication)
2456-3315ISSN
10.57Impact Factor
2016ESTD Year
OpenAccess
Impact Factor 10.57 calculated by Google Scholar and Semantic Scholar.
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 10.57 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
UGC CARE Approved Journal — Transparent Peer-reviewed journal aligned with UGC’s 2025 suggestive parameters, with CrossRef DOI registration and Scopus Standard metadata on every published paper.
Disclaimer:
The content, data and findings in this article are based on the authors’ research and have been
peer-reviewed for academic purposes only. Readers are advised to verify all information before practical
or commercial use. The journal and its editorial board are not liable for any errors, losses or
consequences arising from its use.
Declarations
Funding
No external funding was received for this study.
Conflict of Interest
The authors declare that they have no conflict of interest.
Acknowledgements
The authors would like to thank the reviewers and the editorial board of International Journal for Research Trends and Innovation for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.